Based on this information, it is certainly possible that the Cyp2b’s play a role in lipid metabolism that decreases obesity, provides protection from liver toxicity, but increases NAFLD in female mice because of their much higher expression, greater control, and production of key but as yet not completely understood oxylipins [21]. Here, CYP2B6 is linked to metabolic dysfunction-associated steatotic liver disease.